Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium

Nick Feasey; Raheelah Ahmad; Elizabeth Ashley; Rifat Atun; Kate S. Baker; Francesca Chiari; H. Rogier van Doorn; Alison Holmes; Timothy Jinks; Andrew Jermy; Jyoti Joshi; Souha S. Kanj; Matt King; Direk Limmathurotsakul; Janet Midega; Mirfin Mpundu; Jamie Nunn; Iruka N. Okeke; Stuart Reid; Dawn Sievert; Paul Turner; Kamini Walia; Sharon J. Peacock

doi:10.12688/wellcomeopenres.23494.1

Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium

Nick Feasey, Raheelah Ahmad, Elizabeth Ashley, Rifat Atun, Kate S. Baker, Francesca Chiari, H. Rogier van Doorn, Alison Holmes, Timothy Jinks, Andrew Jermy, Jyoti Joshi, Souha S. Kanj, Matt King, Direk Limmathurotsakul, Janet Midega, Mirfin Mpundu, Jamie Nunn, Iruka N. Okeke, Stuart Reid, Dawn SievertPaul Turner, Kamini Walia, Sharon J. Peacock

Clinical Sciences

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

The increasing threat from infection with drug-resistant pathogens is among the most serious public health challenges of our time. Formed by Wellcome in 2018, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium (SEDRIC) is an international think tank whose aim is to inform policy and change the way countries track, share, and analyse data relating to drug-resistant infections, by defining knowledge gaps and identifying barriers to the delivery of global surveillance. SEDRIC delivers its aims through discussions and analyses by world-leading scientists that result in recommendations and advocacy to Wellcome and others. As a result, SEDRIC has made key contributions in furthering global and national actions. Here, we look back at the work of the consortium between 2018-2024, highlighting notable successes. We provide specific examples where technical analyses and recommendations have helped to inform policy and funding priorities that will have real-world impact on the surveillance and epidemiology of infections with drug-resistant pathogens.

Original language	English
Article number	5
Journal	Wellcome Open Research
Volume	10
DOIs	https://doi.org/10.12688/wellcomeopenres.23494.1
Publication status	Published - 13 Jan 2025

Keywords

Antimicrobial resistance
surveillance

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.12688/wellcomeopenres.23494.1Licence: CC BY

7c258c4d-e202-4b40-bb06-e127d1a16d45 23494 - nicholas feaseyFinal published version, 1.75 MBLicence: CC BY

Cite this

Feasey, N., Ahmad, R., Ashley, E., Atun, R., Baker, K. S., Chiari, F., van Doorn, H. R., Holmes, A., Jinks, T., Jermy, A., Joshi, J., Kanj, S. S., King, M., Limmathurotsakul, D., Midega, J., Mpundu, M., Nunn, J., Okeke, I. N., Reid, S., ... Peacock, S. J. (2025). Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium. Wellcome Open Research, 10, Article 5. https://doi.org/10.12688/wellcomeopenres.23494.1

@article{83c25c494f5c40cf823dc2fb3c226c9b,

title = "Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium",

abstract = "The increasing threat from infection with drug-resistant pathogens is among the most serious public health challenges of our time. Formed by Wellcome in 2018, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium (SEDRIC) is an international think tank whose aim is to inform policy and change the way countries track, share, and analyse data relating to drug-resistant infections, by defining knowledge gaps and identifying barriers to the delivery of global surveillance. SEDRIC delivers its aims through discussions and analyses by world-leading scientists that result in recommendations and advocacy to Wellcome and others. As a result, SEDRIC has made key contributions in furthering global and national actions. Here, we look back at the work of the consortium between 2018-2024, highlighting notable successes. We provide specific examples where technical analyses and recommendations have helped to inform policy and funding priorities that will have real-world impact on the surveillance and epidemiology of infections with drug-resistant pathogens.",

keywords = "Antimicrobial resistance, surveillance",

author = "Nick Feasey and Raheelah Ahmad and Elizabeth Ashley and Rifat Atun and Baker, \{Kate S.\} and Francesca Chiari and \{van Doorn\}, \{H. Rogier\} and Alison Holmes and Timothy Jinks and Andrew Jermy and Jyoti Joshi and Kanj, \{Souha S.\} and Matt King and Direk Limmathurotsakul and Janet Midega and Mirfin Mpundu and Jamie Nunn and Okeke, \{Iruka N.\} and Stuart Reid and Dawn Sievert and Paul Turner and Kamini Walia and Peacock, \{Sharon J.\}",

year = "2025",

month = jan,

day = "13",

doi = "10.12688/wellcomeopenres.23494.1",

language = "English",

volume = "10",

journal = "Wellcome Open Research",

issn = "2398-502X",

publisher = "F1000 Research Ltd",

}

Feasey, N, Ahmad, R, Ashley, E, Atun, R, Baker, KS, Chiari, F, van Doorn, HR, Holmes, A, Jinks, T, Jermy, A, Joshi, J, Kanj, SS, King, M, Limmathurotsakul, D, Midega, J, Mpundu, M, Nunn, J, Okeke, IN, Reid, S, Sievert, D, Turner, P, Walia, K & Peacock, SJ 2025, 'Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium', Wellcome Open Research, vol. 10, 5. https://doi.org/10.12688/wellcomeopenres.23494.1

TY - JOUR

T1 - Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium

AU - Feasey, Nick

AU - Ahmad, Raheelah

AU - Ashley, Elizabeth

AU - Atun, Rifat

AU - Baker, Kate S.

AU - Chiari, Francesca

AU - van Doorn, H. Rogier

AU - Holmes, Alison

AU - Jinks, Timothy

AU - Jermy, Andrew

AU - Joshi, Jyoti

AU - Kanj, Souha S.

AU - King, Matt

AU - Limmathurotsakul, Direk

AU - Midega, Janet

AU - Mpundu, Mirfin

AU - Nunn, Jamie

AU - Okeke, Iruka N.

AU - Reid, Stuart

AU - Sievert, Dawn

AU - Turner, Paul

AU - Walia, Kamini

AU - Peacock, Sharon J.

PY - 2025/1/13

Y1 - 2025/1/13

N2 - The increasing threat from infection with drug-resistant pathogens is among the most serious public health challenges of our time. Formed by Wellcome in 2018, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium (SEDRIC) is an international think tank whose aim is to inform policy and change the way countries track, share, and analyse data relating to drug-resistant infections, by defining knowledge gaps and identifying barriers to the delivery of global surveillance. SEDRIC delivers its aims through discussions and analyses by world-leading scientists that result in recommendations and advocacy to Wellcome and others. As a result, SEDRIC has made key contributions in furthering global and national actions. Here, we look back at the work of the consortium between 2018-2024, highlighting notable successes. We provide specific examples where technical analyses and recommendations have helped to inform policy and funding priorities that will have real-world impact on the surveillance and epidemiology of infections with drug-resistant pathogens.

AB - The increasing threat from infection with drug-resistant pathogens is among the most serious public health challenges of our time. Formed by Wellcome in 2018, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium (SEDRIC) is an international think tank whose aim is to inform policy and change the way countries track, share, and analyse data relating to drug-resistant infections, by defining knowledge gaps and identifying barriers to the delivery of global surveillance. SEDRIC delivers its aims through discussions and analyses by world-leading scientists that result in recommendations and advocacy to Wellcome and others. As a result, SEDRIC has made key contributions in furthering global and national actions. Here, we look back at the work of the consortium between 2018-2024, highlighting notable successes. We provide specific examples where technical analyses and recommendations have helped to inform policy and funding priorities that will have real-world impact on the surveillance and epidemiology of infections with drug-resistant pathogens.

KW - Antimicrobial resistance

KW - surveillance

U2 - 10.12688/wellcomeopenres.23494.1

DO - 10.12688/wellcomeopenres.23494.1

M3 - Article

SN - 2398-502X

VL - 10

JO - Wellcome Open Research

JF - Wellcome Open Research

M1 - 5

ER -

Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this